For example, knowing that 40% of the children with atopic dermatitis will subsequently develop asthma, the Early Treatment of Atopic Child (ETAC) study was a randomized controlled trial of ...

Asthma affects about seven million children in the U.S. But kids who have asthma can lead normal, active lives with the right ...

In its first three years of operation, Medicaid's primary care-focused Accountable Care Organizations (ACOs) in Massachusetts ...

If you have asthma, you may be curious about the many alternatives or additions to prescription medication that people claim can help control symptoms. Social media is full of such claims ...

The following is a summary of “Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor ...

AstraZeneca (NASDAQ:AZN)'s AIRSUPRA, an inhaled anti-inflammatory medication, has shown promising results in a Phase IIIb trial by significantly reducing the risk of severe asthma exacerbations ...

Asthma diagnosis rates shift with age, and that could be attributed to hormonal changes as patients get older. Dr. Albert Polito of Mercy Medical Center joins Jen for a conversation about the factors ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown that almost 1 in 5 asthma patients were dispensed multiple courses of ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

A decade on from Emily’s treatment, its proponents are finding that the cells driving many other diseases, from asthma to heart conditions, share similarities with cancer cells that could allow ...

Obesity increases the risk of nearly 200 diseases and can cause serious health conditions like asthma, strokes ... stigma-free obesity prevention and treatment programs, and evidence-based ...

WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN)'s AIRSUPRA, an inhaled anti-inflammatory medication, has shown promising results in a Phase IIIb trial by significantly reducing the risk of severe asthma ...